about
Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary SyndromeDietary advanced glycation end products and their role in health and diseaseRAGE: a new frontier in chronic airways diseaseGenetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipientsSoluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An OverviewThe effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient miceThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseIntraoperative sRAGE kinetics. A new age-related outcome predictor of cardiac surgery.Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateAGER -429T/C is associated with an increased lung disease severity in cystic fibrosisDeterminants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancerEvidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgeryAdvanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancersRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.The effect of smoking on the symptoms and progression of multiple sclerosis: a review.Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly SubjectsSerum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 DiabetesSoluble RAGEs - Prospects for treating & tracking metabolic and inflammatory diseaseThe Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE.Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in miceManagement of limited joint mobility in diabetic patients.Atherosclerosis and the Hypercholesterolemic AGE-RAGE AxisBiomolecular basis of the role of diabetes mellitus in osteoporosis and bone fracturesAssociation between preoperative plasma sRAGE levels and recovery from cardiac surgery.Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways.GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells.TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus.Cardiovascular risk and dietary sugar intake: is the link so sweet?Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.Platelet activation in obesity and metabolic syndrome.The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.Occurrence of tendon pathologies in metabolic disorders.Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.Alterations of tendons in diabetes mellitus: what are the current findings?Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.
P2860
Q26780488-4FACAB14-56E9-49F0-ADE1-5C16238E4C05Q26801247-84055EFC-C8A2-49BF-90D9-BE787961903EQ27025295-652E70D0-BE8C-40DD-8420-E3A5E67DD12AQ27312010-3D9D420A-5633-4F53-A44B-4C0906FC631FQ27319831-7AECA77F-C577-4490-B170-1FC2DFA975F5Q28386522-9ABD70DC-0722-4318-A106-FF88A351E918Q28535046-A116B9C9-1DAD-49D6-85CC-37E838E56944Q28830568-2DB28DA9-B2E4-4FB4-A1E1-C9334486A56EQ30317651-6925456E-D194-4B7D-9430-29468EB38448Q34286094-DDC8DF58-348B-4B0C-8D08-B908E5E22FA2Q34364298-7C381417-E492-4604-BD6B-60ACCE76E156Q34426525-63D2378D-1943-4298-8559-BB4E7CD822A2Q34987953-B3C41CD4-70EA-49B6-B103-5B5FC639446DQ35068413-24938ABB-FDFE-4753-8201-D471C1153EDFQ35093747-27BA0F6A-DF58-4389-8060-84CFB40CBDE3Q35097016-F03D654E-6ACE-427B-8044-F8320B421842Q35557367-1BA572A4-991F-4876-9083-0BE1DCF4E6EDQ35756983-3E210DAA-92A5-4A83-AEC8-E3DD647BCC6EQ35760856-DA160F88-1270-402A-9045-3A159922E539Q35991574-60D2DFF6-68CD-4695-B379-523F350B1990Q36139994-E2B2453C-938F-4ED6-89D4-792FA1C09603Q36179583-AEEB6F08-0661-4D06-AC5E-0675DEE6BCC7Q36207823-CADBC9A5-5546-4A4D-B5F1-ED1D242AAD86Q36800611-E9FDC1EA-0550-4566-9806-5651E68774E9Q36851848-9AB88972-9302-4E7E-A830-3B2C13EAAB22Q36909193-842B661A-0582-4CB7-98F0-431438405945Q37101614-04308069-19B2-4A69-8D2B-476ACB28C92CQ37191372-EE91E87E-6255-41EB-BE2C-5AF4BF6D83F9Q37263827-8AFE5F14-59AE-43A3-90D2-087D898E560CQ37607192-C662DE3F-A301-4472-8E1B-2F8195CE63DFQ37782025-314D4B00-90AD-4AF2-BAFB-4D3066F7AA5EQ37872223-843F28A3-5BA2-45DE-A99F-E93741EA7EC9Q37908224-37177953-DFC5-405E-A2D0-B47FC325D9CDQ37932076-D5BBB0F9-3378-42F5-AA6D-42E24DCD85A6Q38023062-1EB4A53B-CD27-4251-A45A-EBB48A4B2494Q38073742-2D20EB69-BC2B-4E78-BFBF-566B796C9034Q38108373-F7A5D354-52A2-4944-9373-77DD22D3F3B1Q38131032-5F158EB8-5760-4A3B-A748-9B2E5390FFADQ38461078-CE1B6768-B2D8-448D-A1CC-F82870D0544FQ38698770-02109E0B-4B36-4649-BBAD-E57FB75EC675
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soluble forms of RAGE in internal medicine.
@en
Soluble forms of RAGE in internal medicine.
@nl
type
label
Soluble forms of RAGE in internal medicine.
@en
Soluble forms of RAGE in internal medicine.
@nl
prefLabel
Soluble forms of RAGE in internal medicine.
@en
Soluble forms of RAGE in internal medicine.
@nl
P1476
Soluble forms of RAGE in internal medicine
@en
P2093
Chiara Cuccurullo
Natale Vazzana
P2860
P2888
P304
P356
10.1007/S11739-009-0300-1
P577
2009-09-02T00:00:00Z